Maraviroc
- Product NDC
- 31722-580
- 11-digit product format
- 317220580
- Labeler code
- 31722
- Product ID
- 31722-580_d6904ba1-cfd4-b9e4-e053-2a95a90a1106
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Maraviroc
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Camber Pharmaceuticals, Inc.
- Application
- ANDA203347
- Marketing category
- ANDA
- Marketing start
- 2022-02-06
- Substance
- MARAVIROC
- Active strength
- 300 mg/1
- Pharmacologic classes
- CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Maraviroc
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MARAVIROC | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | MD6P741W8A |
| Rxcui | 728223, 728225 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 31722-580-60 | Maraviroc | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 31722-580 | MARAVIROC (MARAVIROC) TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.] | 2 | Current NDC, Legacy NDC, 1 package rows | 20220209_09ec3e79-c0d3-4b8f-80d8-0a854c4ca339.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 31722-580-60 | 31722058060 | 60 TABLET, FILM COATED in 1 BOTTLE (31722-580-60) | 2022-02-06 | 0000-00-00 | No | No | Current |